These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3145352

  • 1. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract] [Full Text] [Related]

  • 2. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY, Tanimoto H.
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract] [Full Text] [Related]

  • 3. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY, Tanimoto H.
    Antibiot Chemother (1971); 1987 Sep; 39():215-21. PubMed ID: 3118783
    [No Abstract] [Full Text] [Related]

  • 4. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract] [Full Text] [Related]

  • 5. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T, Tateda K, Furuya N, Miyazaki S, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE, Granström M, Vasil ML, Wretlind B, Strandvik B.
    J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)].
    Shinozaki T, Fujii R, Sanai Y, Homma JY.
    Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869
    [No Abstract] [Full Text] [Related]

  • 10. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
    Lydick E, Mclean AA, Woodhour AF, Callahan LT.
    J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R.
    Antibiot Chemother (1971); 1987 Feb; 39():249-55. PubMed ID: 3118786
    [No Abstract] [Full Text] [Related]

  • 13. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
    Steuhl KP, Döring G, Thiel HJ.
    Fortschr Ophthalmol; 1989 Feb; 86(4):283-6. PubMed ID: 2507425
    [Abstract] [Full Text] [Related]

  • 14. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
    Gilleland HE, Gilleland LB, Fowler MR.
    J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
    [Abstract] [Full Text] [Related]

  • 15. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
    Dmitriev BA, Kul'shin VA, Antsiferova NG, Vovk VA, Moroz AF.
    Dokl Akad Nauk SSSR; 1988 Feb; 298(5):1277-80. PubMed ID: 2454182
    [No Abstract] [Full Text] [Related]

  • 16. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Feb; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 17. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS, Vovk VA, Aleksandrov AD, Moroz AF.
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [Abstract] [Full Text] [Related]

  • 18. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D, Vacheron MJ, Guinand M, Michel G.
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [Abstract] [Full Text] [Related]

  • 19. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
    Rutault K, Coin D, Vacheron MJ, Guinand M, Wallach J, Michel G.
    FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
    [Abstract] [Full Text] [Related]

  • 20. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics].
    Brodinova NS, Levdikova GA, Moroz AF.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.